(Q34538321)

English

Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

evasion of host immune response

1 reference

based on heuristic

inferred from title

author name string

N Maeda

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

K Yoshimura

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

S Yamamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

A Kuramasu

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

M Inoue

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

N Suzuki

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Y Watanabe

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Y Maeda

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

R Kamei

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

R Tsunedomi

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Y Shindo

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

M Inui

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

K Tamada

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

S Yoshino

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

S Hazama

15

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

M Oka

16

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

22 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

21 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

S546-54

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

copyright license

Creative Commons Attribution 4.0 International

22 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

B7-H3 over expression in prostate cancer promotes tumor cell progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Clinical importance of B7-H3 expression in human pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

The B7 family and cancer therapy: costimulation and coinhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

B7-H3 and B7-H4 expression in non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Forkhead-box transcription factors and their role in the immune system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

7 July 2018

Mouse B7-H3 induces antitumor immunity.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3564-2

21 January 2018

Evidence for immune defects in breast and lung cancer patients

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3564-2

21 January 2018

Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3564-2

21 January 2018

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3564-2

21 January 2018

FOXP3 expression and overall survival in breast cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3564-2

21 January 2018

B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3564-2

21 January 2018

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3564-2

21 January 2018

Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3564-2

21 January 2018

Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

27 October 2018

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236607

27 October 2018

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3564-2

21 January 2018

Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24562936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24562936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24562936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24562936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24562936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/24562936

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1245/S10434-014-3564-2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

release_gd4avmlghzb7bbjsfa5neo34qm

1 reference

https://api.fatcat.wiki/v0/release/gd4avmlghzb7bbjsfa5neo34qm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34538321&oldid=2196752345"